INTEGRATED CLINICAL TRIAL MANAGEMENT SOLUTIONS

September 2, 2019

As the cost of drug development and time to market increases to exorbitant levels.

Spotlight

SAJA Pharmaceuticals

SAJA is a joint venture between the premier Saudi healthcare company, Tamer, the Saudi partner, the (SA) in SAJA and two of the leading Japanese pharmaceutical companies, Daiichi Sankyo Co., Ltd. and Astellas Pharma Inc., the Japanese partners, the (JA) in SAJA. Both companies are major players in the Japanese healthcare sector, each with an impressive portfolio of ethical medicines.

Other Infographics
news image

What is Adoptive Cell Therapy?

Infographic | February 5, 2020

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More
news image

Pharmaceutical Industry World Economy Scenario

Infographic | May 20, 2022

This product titled One Page Pharmaceutical Industry World Economy Scenario Report Infographic PPT PDF Document is a completely editable document in A4 size designed in Powerpoint.

Read More
news image

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

Read More
news image

What Does The Pharma IndustryWant From CROs?

Infographic | June 16, 2022

Use Informa Pharma Intelligence’s marketing and pharma expertise to conduct industry research, produce engaging thought leadership content,

Read More
news image

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More

Spotlight

SAJA Pharmaceuticals

SAJA is a joint venture between the premier Saudi healthcare company, Tamer, the Saudi partner, the (SA) in SAJA and two of the leading Japanese pharmaceutical companies, Daiichi Sankyo Co., Ltd. and Astellas Pharma Inc., the Japanese partners, the (JA) in SAJA. Both companies are major players in the Japanese healthcare sector, each with an impressive portfolio of ethical medicines.

Events